Podcasts about Jewish Hospital

In this heartfelt episode of The Patient From Hell, host Samira Daswani talks to Jill Massey, a pharmacist and pharma industry veteran whose path through cancer has been both personal and professional. Jill shares her experiences as a caregiver for her sister, mother, and husband—all cancer patients—before becoming a patient herself. They discuss the emotional and practical challenges of navigating caregiving, the complexities of the healthcare system, and how Jill's unique perspective as both a medical professional and a patient shaped her approach to advocacy, treatment decisions, and resilience. Key Highlights: 1. A Personal and Professional Journey: Jill reflects on how her family's battles with cancer shaped her career in the pharmaceutical industry, blending personal empathy with professional expertise. 2. Balancing Roles and Emotions: From sibling to spouse to patient, Jill shares the unique emotional dynamics of each role and the coping mechanisms she developed. 3. Empowerment Through Knowledge: Jill emphasizes the importance of patient education, advocating for personalized care, and the evolving role of pharmaceutical companies in supporting patient-centric care. About our guest: Jill Massey, PharmD, MBA, BCMAS is Vice President, Global Medical Strategy and Operations (GMSO) for Gilead Medical Affairs.  In this role, Jill oversees the Patient-focused Implementation Science team, Medical Strategy and Planning, Insights, Data & Analytics and Digital Innovation, Medical Excellence, Medical Affairs Technology, and Scientific Communications including global publications, medical information, medical external affairs and education, and library and information services.   Jill joined Gilead Sciences from Immunomedics where she led the Medical Affairs, Safety and Pharmacovigilance organizations.  Prior to that, she led Medical Affairs at Janssen, The Medicines Company and Melinta Therapeutics as well as the Melinta Global Antimicrobial Resistance Program. She began her career in the pharmaceutical industry at Bristol-Myers Squibb Company.  Previous to her industry roles, Jill was clinical faculty at the Saint Louis College of Pharmacy, Jewish Hospital and the Program on Aging at Washington University School of Medicine.  Jill is a member of the Board of Directors for the Morris County Chamber of Commerce and serves on the Life Sciences Council Steering Committee.  She is a member of the National Advisory Committee for the Robert A. Winn Diversity in Clinical Trials Award Program, a member of the Accreditation Council of Medical Affairs Executive Leadership Board and a member of the Seton Hall University Transformative Leadership Advisory Board.   Jill earned her Doctor of Pharmacy degree from the University of Nebraska Medical Center and her MBA from Drexel University LeBow College of Business. She completed a residency at Mercer University School of Pharmacy and Emory University. She is Board Certified by ACMA.   Jill loves running, baking and spending time with her two kids, Maddie and Alex, and her loved ones, sometimes including her two dogs and cat. Disclaimer: All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only.  This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Our Guest today is Mary Lu Marizan graduated from Assumption High School attended Jefferson Community College and completed her Bachelor's in nursing from the University of Louisville. She has served as Transplant Coordinator at the University of Louisville. She has also served as Dialysis Home Trainer, University of Louisville, 1985-1989 and has been a Registered Nurse, at Jewish Hospital, Louisville, Kentucky, from 1974-1985. Mary Lu Marzian has been a member of the Kentucky Nurses Association and the American Civil Liberties Union. Mary Lu's Marizan's political career began as a Democratic member of the Kentucky House of Representatives representing District 34 from 1994 to 2023.[1] She retired from the house in 2022 after District 34 was redistricted into district 41st.

Our Guest today is Mary Lu Marizan now running in the Democratic primary for the honor of representing political district 41 in the Kentucky House of Representatives Mary Lu Marizan graduated from Assumption High School attended Jefferson Community College and completed her Bachelor's in nursing from the University of Louisville. She has served as Transplant Coordinator at the University of Louisville. She has also served as Dialysis Home Trainer, University of Louisville, 1985-1989 and has been a Registered Nurse, at Jewish Hospital, Louisville, Kentucky, from 1974-1985. Mary Lu Marzian has been a member of the Kentucky Nurses Association and the American Civil Liberties Union. Mary Lu's Marizan's political career began as a Democratic member of the Kentucky House of Representatives representing District 34 from 1994 to 2023.[1] She retired from the house in 2022 after District 34 was redistricted into district 41st. At that time district 41 was represented by fellow Democrat Josie Raymond. Now Mary Lu Marizan is running again to represent district 41 in the House of Representatives because the incumbent, Josie Raymond, is not running for re-election.

In this engaging episode of the Healthcare Plus podcast, host Dan Collard welcomes Marty Bonick, president and CEO of Ardent Health Services, as they delve into Marty's extensive background in healthcare leadership and his unique perspective as a patient. Marty's journey comes full circle as he shares his experiences as an administrative fellow, junior administrator, and now CEO of Ardent. The conversation highlights the importance of trust in leadership and coordination of care in the post-pandemic world. Marty believes that when we recognize and appreciate what each team member brings to the table, we can bring our best to the patients and the community. He also emphasizes the need for a balanced scorecard approach and the measurement of outcomes to drive continuous improvement.Marty's personal experience as a patient, resulting from a freak accident where he was hit by a car while training for an ironman race, provides a profound shift in his leadership approach. He emphasizes the significance of understanding the patient experience and the need to make meaningful changes in healthcare delivery. Marty and his team at Ardent have launched initiatives such as the "Ban the Clipboard" committee, focusing on enhancing patient interactions and streamlining administrative processes.The conversation further explores Marty's vision for innovation and patient engagement, including attracting and engaging patients through technology advancements such as virtual nursing. Marty's passion for creating an environment where healthcare professionals feel valued and appreciated shines through, as he emphasizes the importance of the "people pillar" and showcasing the unique contributions of Ardent team members.The podcast episode concludes with Marty's advice to aspiring healthcare leaders, emphasizing the importance of integrity, commitment to the triple aim, and resisting the temptation to cut corners. Marty's journey serves as an inspiration for leaders in the healthcare industry to prioritize patient-centered care and continuously strive for improvement.About Marty BonickMarty Bonick is President and Chief Executive Officer of Ardent Health Services. Ardent is one of the largest private health systems in the U.S. with over $5 Billion in Net Revenue, encompassing 30 hospitals and more than 200 sites of care across six states. Ardent employs more than 23,000 people including over 1,200 employed providers who collectively care for over 3 million patient encounters each year.  A veteran health care leader, Mr. Bonick brings 25 years of experience driving business growth through innovation and quality improvement across a variety of health care settings. With experience in for-profit, non-profit, public, and privately held companies, he has held senior management roles in large tertiary and academic medical centers, multi-site systems of inpatient hospital and outpatient facilities, and physician services organizations.  Prior to his appointment as President and CEO of Ardent Health Services in 2020, Mr. Bonick served as CEO of PhyMed Healthcare Group, a national provider of anesthesia and pain management services; Division President at Community Health Systems (NYSE: CYH), where he led operations for a $4.5 billion healthcare portfolio; and CEO of Jewish Hospital and Senior Vice President of Operations for Jewish Hospital & St. Mary's Healthcare in Louisville, Kentucky. Mr. Bonick began his health care career at Hillcrest HealthCare System in Tulsa, Oklahoma, which was acquired by Ardent Health Services during his tenure. 

As you all probably know by now I've been throwing a super fun 1-year flashback to celebrate my Not So Darlin podcast launch in spring 2020! It's been a blast bringing back my most listened-to guests for a "what's happening now" catch up session, and today's finale features Audrey May of Mizuguchi Plastic Surgery. Among other things Audrey is back for a quick update on how the COVID pandemic changed the world of plastic surgery and also gives us the 411 on the newest treatments & correction of the so-called 'tech neck'; how more men are opting for a little bro-tox; and checking out their latest device that utilizes a robot for hair transplants. Audrey graduated from nursing school at the University of Louisville in 2008 and began her nursing career at Jewish Hospital where she gained 8 years of experience in bedside nursing, management and administration. She pursued her passion to become an aesthetic nurse in 2016 during which she truly found her niche. For Audrey her job is the best of both worlds combining her love of science and artistry, and her vast knowledge of both facial anatomy and the eyes for facial contours keeps her extremely busy and very successful. One of the most important things in Audrey's practice is getting to know each of her patients as unique individuals, not just clients. She prides herself in having honest, transparent conversations with each person who sits in her chair and education is one of her primary goals for all patients to help them understand why the aging process is so much more than skin deep. She was voted best injector by her patients back-to-back in the 2019 and 2020 Voice Tribune's "Bestie Awards". Audrey thoroughly enjoys teaching (and pampering!) her patients and loves to watch them achieve their aesthetic goals by enhancing their natural features and beauty. And now, drum roll please: As I celebrate my one-year anniversary I want to celebrate one of you, my listeners/followers who have supported me and helped me grow. So...one lucky randomly drawn winner will receive a full face of Xeomin from award-winning Audrey - 50 units valued at $600 - along with a personalized skin consult with her valued at $250! All you have to do to enter is go to my Instagram @notsodarlintonya & follow instructions. The winner will be announced on @notsodarlin on Tues, May 4. Good luck & thanks! #plasticsurgery #zeomin #byebyewrinkles

In the season finale, we learn about the several attempts to save Lidia's life during World War II and last words from her to those who helped her and her family.  TRANSCRIPT:Welcome to Who was she? Podcast where I, Tara Jabbari share the stories of women throughout Baha'i history. This is the final episode of this season about the life of Lidia Zamenhof, an Esperantist and Baha'i who traveled through three continents to teach languages in effort to bring unity to humankind. On December 9th, 1938, Lidia arrived back in Poland. It took her some getting used to. She wrote, “The highest skyscraper in Warsaw, of which the city is so proud, because it has seventeen stories, cannot impress me anymore.” She wrote about her travels and despite the many hardships she went through, she only spoke of all the friendships she made. Lidia missed teaching Esperanto but decided to focus on translating Baha'i Writings into Esperanto now that she had the time. She also found out about a friend who died in France and wrote to the family expressing her condolences and also her own feelings about death, “Personally, I believe that…the destruction of the human body does not mean the death of the person. This body, composed of atoms, must disintegrate because everything that is composed must decompose. But the higher part of man, his spirit, does not consist of atoms; it is not a combination of chemical elements and is not subject to the law of decomposition. I believe that our consciousness lives on in ways and conditions which we, still living in the body, cannot imagine, just as the little child in the womb of its mother is incapable of imagining the world it will be coming into and for which is being prepared. Those thoughts are a great consolation for me, whenever physical death places a barrier between myself and those I love…”  Her thoughts and beliefs could bring some comfort to others, certainly to her as the world entered a new war that would ultimately be the cause of her death.  By fall, 1939, the Third Reich invaded Poland which began the second world war. After three weeks of trying to fight them off, Warsaw was conquered. Now they were all under the Nazi rule and Jews had to be distinguished from the rest of the population at all times, which meant that Jews had to wear the Star of David on their sleeves and Jewish businesses and schools were closed with their quarter surrounded by fences and barbed wire to keep away from everyone else.  Learning of what was going on and news about Lidia, in particular, were scarce and hard to distinguish from rumor. In November, 1939 the same year that Martha Root died some Jewish newspapers in the US reported that the Zamenhof family were arrested because Lidia had gone to the United States to spread anti-Nazi propaganda.  Esperantists and Baha'is in America worked together to try and save Lidia's life. They contacted the Polish Embassy and the US State Department officials in Berlin but officially, they all said they could not take any action as Lidia was not an American citizen.  Letters sent to Lidia's family were being returned with no forwarding address. But in March, 1940, Stephen Zamenhof, Lidia's cousin who was in New York when the war broke out was able to learn from family in Russia that the whole family had been arrested after the occupation in Warsaw. Adam, her brother was the first to be arrested at the Jewish Hospital where he had been the Director of the Hospital. Then his wife, Wanda and sister Zofia were arrested. His son, Ludwik was spared due to his illness, possibly of typhus and therefore, left at home. Lidia was also arrested. Ludwik eventually was able to share that Lidia and Zofia were released after several months in Pawiak Prison and found a place to stay in Ogrodowa Street since the Zamenhof home had been destroyed during the bombardment of Warsaw. Adam was sent to Danilwiczowska Prison. Eventually, it was learned that at the end of January, 1940 Dr Adam Zamenhof had been shot and killed with a hundred other intellectuals and professionals.  Meanwhile, an Esperantist, Jozef Arszenik who was taught the Baha'i Faith by Lidia visited her before the Ghetto was sealed off. He offered to hide Lidia in his home on the outskirts of Warsaw. After the war, Mr. Arszenike wrote: “That noble woman refused my offer to save her, saying that I with my family could lose our lives, because whoever hides a Jew perishes along with the Jew who is discovered.” He also wrote that Lidia's last words to him were, “Do not think of putting yourself in danger; I know that I must die, but I feel it my duty to stay with my people. God grant that our of out sufferings a better world may emerge. I believe in God. I am a Baha'i and will die a Baha'i. Everything is in His hands.” After the war, Mr. Arszenik became a Baha'i and lived till the age of 80.  There are accounts of attempts to save Lidia's life, one in particular which is what personally inspired me to learn more about Lidia. In the late 1930s, for Germany, it was clear all signs pointed to a war. A German Baha'i, Fritz Macco and his brother and friends were worried about what that meant for them. As Baha'is, they must obey their government but also as Baha'is, they did not want to fight and did not agree with Germany's politics The men wrote a letter to the Guardian of the Baha'i Faith, Shoghi Effendi, for guidance. The Guardian reportedly replied that if their desire not to take a life was sincere, God would assist them in attaining it. Fritz and his brother and friends were soon drafted into the army. all of them died in the first week of the war with the exception of twenty-four-year-old Fritz. He was sent to Warsaw as an ambulance driver for the German Army which allowed him to not be in a non-combatant duty. He was puzzled as to why he was spared but when he arrived in Warsaw and found Lidia, he believed he was spared to help save her life. Again, Lidia refused to leave “her people” and though he could not save her life, Fritz would go on to help the Resistance and save many other Jews and Baha'is in occupied land, including his own mother. Sadly In September 1944, Fritz was killed. By 1942, there was scarce information on Lidia but she was able to send a postcard to a friend in Holland sharing that Zofia and sister-in-law, Wanda are working as doctors in the Ghetto. Although she never wrote it down, it was probable that Lidia was teaching others English. This was against the law as English was considered the enemy's language under-occupied Poland but it gave people hope. But in July 1942, there was the order that all the Jews of the Warsaw Ghetto were to be “deported to the east,” to a camp called, Treblinka.  While Wanda and her son Ludwik were able to escape and survive outside the Ghetto during the deposition, Lidia and Zofia were not able to. They were taken 120 kilometers from Warsaw to Treblinka. The death camp was about fifty acres and surrounded by antitank barriers and barbed wire with watchtowers in each corner. There were gas chambers and burial pits where the bodies were disposed of originally by lime then later by burning on large iron racks. Eventually, Nazis became worried that the mass graves might be discovered so they exhumed and burned them. It is calculated that one million, two hundred Jews died at Treblinka including Lidia and her sister. The author of Lidia's biography Wendy Heller writes, “Among the ashes in the ground at Treblinka are those of Lidia Zamenhof.” She was thirty-eight years old.  After the war, it was discovered that miraculously, the Jewish cemetery had not been destroyed and Ludwik Zamenhof's tomb still stood. There eventually would be a plaque set in place on Klara Zamenhof's grave with the names of Lidia and Zofia, that reads “Murdered in the year 1942. Let the memory of them last forever.” There was a memorial service held in honor of Lidia by the Baha'is of the United States and Canada on the week of October 25th, 1946. Lidia refused to allow others to endanger themselves in order to save her, she felt a duty to be with her family and the Jewish community. Lidia never hid away from trying to find meaning in the world. She found love in faith and language that she believed would unite everyone. She believed what truly mattered was how someone faced a challenge. I leave you with Lidia's own words, “behind the densest clouds the sun is shining, that the Most Great Peace will come.' ‘Whoever can still find in his heart a single ray of faith, as delicate and any as a spider's thread, will not perish in the abyss, but even if all the powers of this world rise to struggle against him to push him down, even in the fall itself he will stop, and by this ray, as why the biblical ladder, even out of the abyss will ascend to heaven.' This has been Who was she? Podcast, follow us on our Instagram, Facebook and Pinterest @whowasshe podcast. And please, rate and subscribe wherever you listen to this podcast. Logo was designed by Angela Musacchio. Music was composed and performed by Sam Redd. I am your host, Tara Jabbari.    Get bonus content on Patreon Hosted on Acast. See acast.com/privacy for more information.

The first pager system was used by the Jewish Hospital of Brooklyn. Although associated with drug dealers, by the 1990s beepers became popular among teenagers, who developed elaborate codes based on numerical displays.

Use Promo Code DarlinAesthetics for a 10% off discount! Audrey graduated from nursing school at the University of Louisville in 2008 and began her nursing career at Jewish Hospital where she gained 8 years of experience in bedside nursing, management and administration. She pursued a passion to become an aesthetic nurse in 2016 where she truly found her niche. Audrey assists Dr. Mizuguchi with his surgical patients and also sees many of her own injectable patients. When seeing her patients she starts with a thorough consultation to learn more about their unique goals to ensure she selects the best products or treatments for them. Some recommendations may include neuromodulators such as Botox, Dysport, or Xeomin and fillers like Restylane, Juvederm or Radiesse. She may also suggest devices that work to tighten, lift, sculpt, or reduce fat on various areas of the face and body. She was voted best injector by her patients in the 2019 Voice Tribune's Bestie Awards. Audrey thoroughly enjoys teaching and pampering her patients and loves to watch them succeed at their aesthetic goals! Instagram @audreymay047 @goldscalpel

A Big Thank you from the Egyptian West Island Community to all the Health workers in the Jewish Hospital, who fights relentlessly this Pandemic of the COVID 19

As the medical device industry continues to speak the new mantra of "Patient Outcomes", device safety and sterility has become an enhanced topic of discussion. In this episode, our guest Michael Matthews of the Beyond Clean Podcast speaks on issues that must be addressed in the SPD departments in order to assure the safe and sterile delivery of surgical instruments to the OR. The interplay of People, Processes and Products must be understood to better manage the complicated work environment in the SPD.Guest Description:Michael Matthews, MBA, CLSSGB, CRCST, CIS, CHL currently serves as the Director for Clinical Education and Training for Northfield Medical, where he previously served as a Territory Manager for the Little Rock, Arkansas area, and a Clinical Education Manager for the southeast region. Before working at Northfield, Michael served as the manager for sterile processing at Baptist-Health Medical Center-Conway, a new $200 million facility in Arkansas.During this time Michael also served as an Infection Preventionist on a PRN basis to consult on reprocessing services throughout the Baptist-Health system. Michael has previously served as a Sterile Processing Technician at Jewish Hospital & St. Mary’s Healthcare (Catholic Health Initiatives) (2012-2013), Baptist East Hospital (2011-2012), both in Louisville, KY, and system manager for sterilization and high-level disinfection at Conway Regional Medical Center (2013-2016).He holds three International Association of Healthcare Central Service Materiel Management (IAHCSMM) certifications for sterile processing. Michael has also served as a subject matter expert and participated in exam development for IAHCSMM. Michael holds an MBA and has also been certified as a Lean Six Sigma Greenbelt. He has published articles in Infection Control Today, Becker’s Hospital Review, Healthcare Purchasing News, as well as several LinkedIn articles in the sterile processing community.Michael is a co-host of the Beyond Clean podcast, the premier podcast for sterile processing professionals throughout the world, and the lead host for Beyond the Headlines, which examines news related to the medical device reprocessing industry. https://www.beyondclean.net/

On the Access Louisville podcast this week we dive into a few very different topics.As always, we start the show with a light topic. I ask the panel what their favorite local music venue is and get some interesting answers. A recent story about a new music venue coming to town got me thinking about this.After that, at the 4:08 mark, Reporter Chris Larson tells us about University of Louisville’s $379M plan to expand University Hospital. This is a contingency plan if its deal to buy Jewish Hospital doesn’t work out. After that, at the 9:08 mark, Reporter Haley Cawthon gives us an update on some restaurant news including renovations at BoomBozz, new NuLu restaurants and SOU on Louisville’s East End.Access Louisville is a weekly podcast from Louisville Business First. Business First editors David A. Mann and Brooke Timmons are also on the show.

On Access Louisville this week the panel discusses the new Roots 101 African-American Museum at 819 W. Main St. on Museum Row. The museum is still raising funds for a renovation project. There's a tentative opening date set for January 2020. That discussion starts at the 5:21 mark.At the 11:46 mark, Reporter Chris Larson also tells us about his tense trip to Frankfort where legislators grilled U of L about a $50 million loan for its takeover of Jewish Hospital.

This week, Jazmin and Robert talked about four major stories and several quick hits.  Jazmin explains Andy Beshear's plan to raise teacher pay by at least $2000, and Amy McGrath's new problem with coal miners in her ads.  Robert describes the several different ads that have either appeared on our televisions, or which have been bought and will appear soon and Sen. Morgan McGarvey's concerns about UofL hospital's acquisition of Jewish Hospital.  And of course, Quick Hits!

Football is finally hear, but before the games begin Chris and Gabe got a few things to check in on. The boys have a frank conversation about the reaction to Andrew Luck's retirement and how twitter takes rob us of real conversations. They dive deep into Scott Satterfield's first preview press conference and the expectations for Puma Pass. Also covered are reactions to Coach Cal golfing with Obama, Chris' thoughts on UofL purchasing Jewish Hospital, the extensive Governor's race debate schedule and of course the latest from Matt Jones. Follow Us: * CHECK OUT THE NEW WEBSITE * Subscribe to our newsletter * The Pod on Instagram * Gabe on Twitter * Chris on TwitterFind out more at https://what-high-school-did-you-go-to.pinecast.coThis podcast is powered by Pinecast.

This week In Conversation, we talk about the University of Louisville's plans to buy Jewish Hospital and other properties and how those plans could affect the commonwealth. U of L announced last week that it had cemented plans to buy the hospital and other facilities owned by its parent company for $10 million. But it hinges on a $50 million loan from the state, and lawmakers said a special session to approve that loan might not happen. Our panel talked about the plan and what the hospital means to the community. Guests included State Senator Morgan McGarvey (D-Louisville), State Senator Stephen Meredith (R- Leitchfield), WFPL Health Reporter Lisa Gillespie and University of Louisville Emeritus Professor of Medicine Peter Hasselbacher.

This week we welcomed Democratic Leader Rocky Adkins to the show!  He's been a mainstay of Kentucky politics dating back to the late 1980s.  We talked to him about leading the Democratic caucus in the House, his recent run for Governor, and what Democratic message can unite urban and rural Kentuckians.  He spoke openly and honestly and we were thrilled to welcome him to MOKP. We also covered plenty of news items!  Lt. Governor Jenean Hampton is suing former ticket-mate Governor Matt Bevin, Matt Jones has been ousted from Hey Kentucky (and some media outlets are reporting Amy McGrath's campaign might have something to do with that), and Jewish Hospital is being acquired by the University of Louisville.  We talked through these major stories and more.

Welcome to the Mercy Health Medical Minute, it’s brought to you by Mercy Health. This week we have back Dr. Vincent DiNapoli, MD is an experienced Neurosurgeon and the Director of the Brain Tumor Center at Jewish Hospital. We'll be talking about brain tumors.

Bill Bryant and a panel of journalists discuss the week's news from around the state, including the latest on the general election political races and a move by the University of Louisville to purchase Jewish Hospital. Guests: Lawrence Smith from WDRB-TV in Louisville; Deborah Yetter from the Louisville Courier-Journal; and Wes Swietek from the Bowling Green Daily News.

Bill Bryant and a panel of journalists discuss the week's news from around the state, including the latest on the general election political races and a move by the University of Louisville to purchase Jewish Hospital. Guests: Lawrence Smith from WDRB-TV in Louisville; Deborah Yetter from the Louisville Courier-Journal; and Wes Swietek from the Bowling Green Daily News.

This week in Kentucky politics, Lieutenant Gov. Jean Hampton filed a lawsuit against Gov. Matt Bevin for firing two of her staffers. The University of Louisville announced a deal to try and buy the struggling Jewish Hospital system with a $50 million loan from the state. And sports radio host Matt Jones announced he’s writing a book about Mitch McConnell, but still won’t say if he’s running against him. Kentucky Politics Distilled wouldn't be possible without you. Click here to support the work we do.

Louisville Muhammad Ali International Airport is getting a new direct flight! Sounds exciting, right? Maybe not so much. The new flight is to Sarasota, Fla. Don't get us wrong, Sarasota is a fine destination. But Louisville already has direct flights to eight different airports in Florida. Wouldn't it have been nice to pick up a new direct flight to another state instead?We talk about that on this week's episode of Access Louisville.That's one of just a few topics of discussion this week. We also dive into the huge news about University of Louisville buying Jewish Hospital. And we talk about the recent rumor that Louisville could be in line for a new soccer team.

Claudia Cragg (@KGNUClaudia) speaks here with Ran Poliakine, a serial entrepreneur, inventor and industrial designer. In 2007, Poliakine founded , a company that utilized  technology to develop  solutions. Then, in 2009, through Wellsense he developed the world’s first bedsore monitoring system and the Monitor Alert Protect (MAP) system. This continuously monitors a patient to display potential development of high-pressure points that lead to  and and is used in major hospitals throughout the world and in the US including the , ,  and Kentucky’s Jewish Hospital. Today he is involved in a myriad of new companies all developing far-reaching new technologies.  Poliakine was born in ,  where he lives with his wife and five children.  You can find .  

Welcome to the Mercy Health Medical Minute, it’s brought to you by Mercy Health. This weeks guest is Dr. Vincent DiNapoli, MD is an experienced Neurosurgeon and the Director of the Brain Tumor Center at Jewish Hospital. We'll be talking about metastatic brain tumors this week.

Welcome to the Mercy Health Medical Minute, it’s brought to you by Mercy Health. Dr. Vincent DiNapoli, MD is an experienced Neurosurgeon and the Director of the Brain Tumor Center at Jewish Hospital, we’re going to be discussing that this week.

This week, Jazmin and Robert update a story from last week about Andy Beshear's lawsuit against Gov. Bevin's Labor Cabinet (news broke on this story in the middle of recording!), whether or not a special session would happen this year, and about Adam Edelen's negative ads attacking Andy Beshear.  Plus, Quick Hits from topics as varied as Jewish Hospital in Louisville to the Fairness Ordinance vote in Bowling Green.  Enjoy!

The weekly podcast features Power Women such as Judge Judith Sheinlin of “Judge Judy,” Pat DiMango of “Hot Bench,” New York City Census Director […]

Dr. Stuart Williams, founder of Bioficial Organs (cvregen.com), delivers an interesting overview of the future of bioengineered organs and tissues, and the medical advances that we are seeing daily. Williams has extensive experience in the areas of biomedical engineering, surgery, physiology, as well as materials science and engineering. He is the former director of research for the Department of Surgery at Jefferson Medical College, former faculty at the University of Arizona, and founder of the University of Arizona Biomedical Engineering Program. In 2007, Williams was appointed as the scientific director of the Cardiovascular Innovation Institute, a collaborative partnership between the University of Louisville and Jewish Hospital. Williams received a Ph.D. in cell biology from the University of Delaware and did his postdoctoral training in pathology at the Yale School of Medicine. His strong interest in medical devices and regenerative medicine paved the path toward his development and patent of one of the first methods to use fat-derived stem and regenerative cells for therapeutic use. Dr. Williams discusses the Bioficial Organs Program and their work to create human tissues and organs for clinical therapeutics and in vitro drug efficacy and toxicity testing by utilizing a patient's own cells. He gives a detailed overview of the fascinating process of creating organs and tissues from biological parts. As Williams explains the human body has at least eleven different types of organs and tissues, some that are extremely complex, but some that are simpler, that can be created via the Bioficial process. He explains how the complexity is often based in the number of specific cells that are used to perform functions. As he states, the liver and the kidney are perhaps more difficult to bioprint than other organs, but that parts of tissues, such as skin, are easier to tackle successfully in regard to regenerative medicine. He discusses work they are very excited about, including their active lab program to use 3D bioprinting to create an artificial pancreas, in order to produce insulin on demand in a patient.  The biomedical engineering expert discusses specific organs that can regenerate, and those that cannot. Unfortunately, for example, the heart does not have cells within it that will repopulate a damaged area, but it may be possible to put organoids into a damaged part of the heart such that they may take up residence and begin to create a functional part. Williams discusses his extensive work focused on developing new and successful ways to remove patients' cells and build new blood vessels from those cells that can be reinserted into the body. He cites examples of some specific work with patients that helped to advance the regenerative medicine field.  Dr. Williams discusses their exciting new plan to move bioprinting to the international space station, which will allow them to avoid the effects of gravity that can adversely impact some of their work. He relates how the fetus is formed in amniotic fluid, and thus is somewhat defying gravity as it can move about freely in its environment. And this study of those conditions, in fact, creates more questions as well as answers to how growth happens regarding organs, and the conditions and mechanisms that are involved in that complex process. Further, he discusses the shapes of organs, and how it may not be necessary to recreate organs in the same shape in which they naturally occur in the body. Additionally, he muses about regeneration, and why some organs will regenerate, but others will not, and he states that he is very interested in studying all of these issues in detail to find the answers.  Dr. Williams has authored more than 300 scientific publications and his work has generated 22 issued US patents with nearly countless patents pending. He's the founder of six biotechnology companies and is a fellow of the American Heart Association as well as the American Institute of Medical and Biological Engineering.

There are a lot of terms that could define entrepreneurship: Risky, busy, confusing, overwhelming, fun, inspiring, and on and on. Starting and growing your own business is one of the most challenging adventures a person can go on. But there’s another word used a lot to describe owning a business and that’s lonely. So many entrepreneurs describe moments of isolation. Maybe it’s physical isolation, especially early on but more often, the isolation is mental. The buck stops with you. And that means every idea, every decision ultimately falls on your lap. Your left to ponder not only the future but also the past. Maybe there’s an entrepreneur out there who’s got it all figured out but most of us, we’re obsessed about decisions, paths, and outcomes. Each tiny moment swirls inside our head. What’s right, what’s wrong, where should the money go and where did the money go. At first we’re constantly sharing every thought and idea with friends and family. But one subtle cue after another teach us to stop talking about it all the time. These people love us but they don’t really understand. So we recess, into ourselves and, well, feel kind of lonely. This is why smart business owners find people to talk with, to bounce ideas off of, that they trust to listen and more importantly, to provide a reflection from the real world of what’s actually going on. Take this podcast, Scratch Entrepreneur. I think it’s cool, of course, or I wouldn’t do it. I obsess about it. How to structure interviews, music, hosting, microphones, everything. But to be honest, I’m not totally sure what’s good and what isn’t. It’s a lonely feeling to think you’re doing something great and at the same time have no idea. I clearly need to reach out and find a community of trusted advisors. Today’s guest has built a business around solving this issue. He helps bulls thrive in china shops. He’ll explain that a little later on but the essence of David Quick’s business is to remove that isolation from the equation. To provide a coach, a mentor, a mirror reflecting the perspective from outside. As it turns out, he’s been playing that role since some kid asked him in middle school to help play a middle c. This interview is peppered with life lesson and advice on business ownership. David has seen it all, and he has an unusual ability to break life lessons into simple memorable anecdotes that will make you a better business owner and a better person. So strap in for the stories and advice of David Quick. What were formative moments that made you who you are? David was a great saxophone player as a kid. As he got into high school younger kids would ask him to teach them how to play. So he would. He learned at that point that teaching and coaching were things he loved. So how did you end up at the highest levels of corporate America? That road traveled through the Navy. David spent over a decade as a Naval officer and he attributes much of his adult foundation to that. When he finally left the Navy he really had no idea what to do. There was an opportunity wselling laboratory equipment, so he took it. The life lesson there was learn the lingo, look for a guide, and work hard. As soon as David got planted in the laboratory sales world he started climbing ladders. He buzzed through companies like Miles Laboratories that became Bahr Laboratories. He mastered the sales process, took on leadership roles, and generally was always moving up to the next thing. Then he started getting hired to grow businesses. Later in his career he landed at Roach Laboratories involved in innovative projects that essentially gave David to opportunity to spend company money to start businesses under the umbrella of Roach Diagnostics. From there he dug into the venture What are the core questions you ask new clients? What does Thriving mean? Who do you wanna be? What do you wanna do? What do you wanna have? David’s experience with his coach finding the best way to thrive You have the herd you deserve Do you have the people in the right seats What’s the foundation every business needs? Vision – This is all about the picture that the founder has for the business. What does it mean to Thrive? Core Values – Who are our model citizens? Who are the people we want to clone? What are the characteristics associated with that?Expectation – Are you the New England Patriots or the Cleveland Browns. Engagement - How are the three above pieces integrated into everyday life? Special thanks to David Quick for taking the time to share the Helping Bulls story with us Mentioned in the episode: • Jewish Hospital in Cincinnati • Miles Laboratories www.bayer.com • Bayer Laboratories • Wall Street Journal  • J&J Laboratories  • Roche Diagnostics • Mastermind  • Culture Index  • New England Patriots  • Cleveland Browns • Chicago Cubs  • Theo Epstein  • Joe Madden  • Music by Mark Vinten The show was produced and edited by me Jeremy Goodrich. The music is by my high school buddy Mark Vinten. Every morning he would swing by and pick me up for school. Mark’s school taxi was one of my favorite vehicles ever a 1980 Volkswagon Vanagon poptop. If you enjoyed this podcast, there’s a couple of things we need you to do right now. First subscribe to Scratch Entrepreneur on itunes, Stitcher, Google Play or wherever you listen to podcasts so you can hear future episodes as soon as we release them. While you’re there, please give the show a review. We’d love to know what you liked, what you didn’t, and what you want to hear next. Then, please share the show with whoever you think it will inspire. Until the next time, We truly appreciate you listening.   Need Shine? More great stories & information at: Youtube - Blog - Podcast Facebook - Twitter

Better known in the wider hobby by the nom de coin “R. Tettenhorst” (which was actually the name of his secretary, to whom his packages were addressed), Bernard Edison--“Bunny” to his friends--carefully assembled his collection over a lifetime of business and civic success in the St. Louis, Missouri area. A member of the Edison family of Edison Brothers Stores fame, Bernard was born on March 23, 1928. Having graduated from Harvard University in 1949, Bernard then studied at Harvard Business School - even though he could have earned a PhD in mathematics instead. And despite his prestigious education, Bernard served his country during the Korean War as a lieutenant in the U.S. Air Force. Joining the family business, Bernard had become president of the company by the early 1970s. Edison Brothers Stores already had been expanding into different areas of the shoe and retail markets for over a decade, and under Bernard’s leadership the company continued to grow and expand - operating about 2,000 retail locations by the end of the ‘70s and achieving over $1 billion in sales by the mid-’80s. He stepped down in 1987 but continued to advise the company as a new generation of the family took over. It might be worth noting that fellow St. Louis coin collector (and Edison’s relative through marriage) Eric P. Newman worked as an executive vice president at the company during this same time period. Bernard also served on the corporate boards of several other companies, including Anheuser-Busch, General American Life Insurance Company, Mercantile Bancorporation, and Reinsurance Group of America. He also played an important role in many civic and philanthropic organizations over the course of his life, including BJC Health System, Civic Progress Inc., the Harry Edison Foundation, the Jewish Hospital of St. Louis, St. John’s Mercy Medical Center, and the United Way of Greater St. Louis. Bernard is also remembered for his patronage of the arts and the restoration of the old Edison Brothers warehouse in downtown St. Louis. As a collector, Edison is famous for what is commonly called the “Missouri Cabinet” of U.S. Half Cents, one of the greatest collections of copper half cents ever assembled. Edison himself named it the “Davy Collection” after his youngest son (who is said to have worn a shirt that said “I’m Davy” to the sales), though it has come to be known best by the aforementioned name given to it by the late numismatist Walter Breen. The collection was auctioned publicly by the Goldbergs on January 26, 2014 at the Long Beach Expo. Bernard Edison died on April 18, 2018. He is survived by his wife Marilyn Sue (née Wewers); his children Julie, Robin, Peter and David; and two grandchildren Jack and Benjamin. A memorial service was held at Temple Emanuel in St. Louis on Sunday, April 22. (c) 2018 CoinWeek, LLC.

Allan is a 1980 graduate of Baylor College of Dentistry in Dallas, Texas. After dental school he attended a General Practice Residency at the Jewish Hospital in St. Louis, Missouri where he experienced dental O.R. cases delivered by Certified Registered Nurse Anesthetists. After ten years of private practice he said, " I want to do Anesthesia." So while still practicing dentistry part-time, he got his Bachelor of Science in Nursing degree through the Accelerated Option at St. Louis University, worked in the ICU at the VA in St. Louis for a year, and then attended the Nurse Anesthesia program at Washington University in St. Louis at Barnes Hospital.    www.SedationConsult.com

Madeline Abramson served as Louisville’s first lady for 21 years and is a tireless community volunteer. As the wife of the longest serving mayor in Louisville history, Mayor Jerry Abramson, Abramson has selflessly devoted a great deal of her efforts to volunteerism. Her passion for public service has placed her as the board chair for the Kentucky Center for Performing Arts and the Red Cross, and leading the board at Maryhurst. Abramson has also served on the board for the Prichard Committee for Academic Excellence and St. Mary’s Foundation at Jewish Hospital. Abramson has earned some very high honors for her many volunteer commitments, including the Ira J. Porter Award from the American Red Cross, the Maryhurst Shepherd’s Heart Award, the Hannah G. Solomon Award, the Family Scholar House Lucy Award, and an honorary doctorate in public service from Spaulding University.

Dr. Carolyn Lam:               Welcome to Circulation on the Run, your weekly podcast summary and backstage pass to the journal and its editors. I'm Dr. Carolyn Lam, Associate Editor from the National Heart Center, and Duke National University of Singapore. Our featured paper today provides important trial evidence that will guide interventional management of symptomatic femoral artery disease, but first, here's your summary of this week's journal.                                                 The first paper sheds light on the interaction between left ventricular dysfunction and mesenchymal stromal cell activation. First author, Dr. Naftali-Shani. Corresponding author, Dr. Leor and colleagues from Neufeld Cardiac Research Institute in Israel isolated mesenchymal stromal cells from cardiac and subcutaneous fat tissues of mice with left ventricular dysfunction, 28 days after myocardial infarction or sham operation. They further injected mesenchymal stromal cells or saline into the infracted myocardium of mice and evaluated left ventricular remodeling 28 days after myocardial infarction. They found that left ventricular dysfunction switched cardiac mesenchymal stromal cells towards an inflammatory phenotype and that these pro-inflammatory mesenchymal stromal cells contributed to adverse left ventricular remodeling and dysfunction. The inflammatory polarization of cardiac mesenchymal stromal cells by left ventricular dysfunction was mediated by toll-like receptor four. Finally, toll-like receptor four deficiency in mesenchymal stromal cells attenuated their pro-inflammatory activation, improved their reparative properties, graft survival, infarct repair and left ventricular remodeling.                                                 In summary, the environment of the failing and infarcted myocardium drove resident and transplanted mesenchymal stromal cells towards a pro-inflammatory phenotype that restricted their survival and reparative effects in a mechanism mediated by toll-like receptor four. Targeting toll-like receptor four in mesenchymal stromal cells could improve the safety and efficacy of cell therapy in heart failure.                                                 The next study provides evidence that fractional flow reserve or FFR is a useful index for decision-making in real life daily cath lab practice. First author, Dr. Ahn, corresponding author, Dr. Park and colleagues from Heart Institute Asan Medical Center in South Korea, evaluated the prognosis of deferred and revascularized coronary stenosis after FFR measurement in the IRIS-FFR registry of 5,848 prospectively enrolled patients. This large prospective registry showed that the FFR was linearly associated with the risk of cardiac events in deferred lesions. In addition, revascularization for coronary artery stenosis with a low FFR of less than 0.75 was associated with better outcomes than deferral, while for a stenosis with a high FFR of greater than 0.76, medical treatment would be a reasonable and safe strategy. Thus, the authors concluded that FFR may be considered a clinical prognostic index in addition to a physiological quantification for flow-limiting stenosis. These and other issues are discussed in an accompanying editorial by Doctors De Bruyne, Fournier and Barbato.                                                 The next study sheds important insights into a potential disease modifier in pulmonary arterial hypertenstion, and that is vascular endothelial growth factor receptor three, or VEGF receptor three. First author, Dr. Hwangbo, Co-corresponding authors Dr. Chun and Dr. Jin from Yale Cardiovascular Research Center in Connecticut, used a combination of experimental animal models, human patient cells and detailed signaling studies to demonstrate the importance of a novel interaction between bone morphogenetic protein type two receptors, or BMPR2 and VEGF receptor three in regulating the robustness of endothelial bone morphogenic protein signaling response. They demonstrated that the interaction was critical for promoting BMPR2 internalization in response to bone morphogenic protein stimulation. They further showed that genetic deletion of endothelial VEGF receptor three in mice resulted in exacerbation of chronic hypoxia-induced pulmonary hypertension and impaired bone morphogenic protein signaling. Thus, these findings identify VEGF receptor three as a key regulator of endothelial BMPR2 signaling and a potential determinant of pulmonary arterial hypertension penetrance in humans.                                                 The next study tells us that a low-dose drug-coated balloon may be a promising treatment option in symptomatic superficial femoral or popliteal artery disease. Dr. Schroeder and colleagues of the Jewish Hospital in Berlin, Germany, reported results of the ILLUMENATE European Randomized Clinical Trial, which was a prospective randomized multi-center, single-blinded trial, where patients were randomized 3:1 to treatment with a low-dose drug-coated balloon or an uncoated percutaneous transluminal angioplasty balloon. The primary safety endpoint was a composite of freedom from device and procedure-related death through 30 days, and freedom from target limb major amputation and clinically-driven target lesion revascularization through 12 months. The primary effectiveness endpoint was primary patency at 12 months. The main results were that in symptomatic patients, with superficial femoral and/or proximal popliteal artery disease, low-dose, drug-coated balloon was safer and more effective than uncoated percutaneous transluminal angioplasty balloons through follow-up of 12 months. This is discussed as a novel strategy to reduce femoral popliteal restenosis in an accompanying editorial by Doctors Goldsweig and Aronow.                                                 The final study provides important genotype-phenotype correlations of SCN5A mutations in probands with Brugada syndrome. First author, Dr. Yamagata, corresponding author, Dr. Shimizu and colleagues of Nippon Medical School in Tokyo, Japan, studied 415 Japanese Brugada syndrome probands to assess the association between SCN5A mutations and clinical outcomes. During a mean follow-up period of 72 months, the overall cardiac event rate was 2.5% per year. Compared to probands without mutations, probands with SCN5A mutations experienced their first cardiac event at a younger age, had a higher positive rate of late potentials and exhibited longer P-wave, PQ and QRS durations, and had a higher rate of cardiac events, especially when the mutations were located in the pore region of the encoded protein. The conclusion was therefore, that genetic screening for SCN5A mutations among Brugada syndrome probands may be useful for stratifying such patients according to their risk of subsequent cardiac events. Well, that wraps it up for your summaries. Now for our feature discussion.                                                 Our feature paper today is the stuff that really could change guidelines. Now, we're talking about superficial femoral artery disease and its treatment. Unlike most other vascular beds, where stenting is the preferred modality of endovascular revascularization, the optimal therapy for superficial femoral artery disease remain controversial. However, today's paper really adds to our insight and I am so pleased to have the first and corresponding author Dr. Ilka Ott, from German Heart Center in Munich, as well as Dr. Manos Brilakis, Associate Editor, from UT Southwestern. Welcome both. Dr. Ilka Ott:                         Welcome. Dr. Manos Brilakis:           Morning. Dr. Carolyn Lam:               Wonderful. So Ilka could you please share what you found? Dr. Ilka Ott:                         We already know from previous studies there has been a lot of studies showing the drug-eluting balloon is superior to plain angioplasty in superficial artery disease. So then, in our study, we found that the treatment with the drug-eluting balloon plus stenting was very superior to the balloon angioplasty plus stenting and the directional atherectomy. The primary endpoint we used in the study was an angiographic endpoint. It was diameter of stenosis and this was significantly lower in the patients treated by drug-eluting balloon angioplasty, as compared to the balloon angioplasty and atherectomy group. Moreover, we had a clinical follow-up of 24 months and we found that also the target lesion revascularization was 70% in the group of drug-eluting balloon plus stent as compared to 37% in the balloon angioplasty and stent group, and 53% in the atherectomy group. We found a significant reduction also in the clinical endpoint of TLR at three years. Dr. Carolyn Lam:               Wow Ilka, congratulations, but may I just ask, was there any reason to think that a drug-eluting balloon would not be similarly beneficial as in other vascular beds? Dr. Ilka Ott:                         Well, I think is not a novelty of the study. We already know from previous studies that drug-eluting balloon is superior to plain balloon angioplasty so that's not a surprising result. However, in disease of the femoral superficial artery we often have the problems, in particular when we treat complex lesions like along occlusions or along calcified stenosis, that drug-eluting balloon is not sufficient, so you need to also stabilize the lesion to stabilize dissections. You also need to do a stent implantation. Our study now shows that the combination of drug-eluting balloon plus stent is superior than plain balloon angioplasty plus stent. The nice approach is most of the time if you need a stent, if you use drug-eluting balloon and the lesion is stable and you don't need a stent you are glad. This has shown previous studies, however, if you need further treatment and you need to place a stent, we now show that the pretreatment with a drug-eluting balloon is a superior option than just the plain balloon angioplasty. Dr. Carolyn Lam:               Manos, what is your take on these results? Do you think it will impact guidelines? Dr. Manos Brilakis:           First of all, I would like to congratulate Dr. Ott for an excellent study. I think what is particularly important here, is the comparative effectiveness component. We have several studies circulating already about drug-coated balloons, have studies on stents, but we don't have studies addressing the other modalities like atherectomy. Why I was particularly impressed, is I think the study will have a finally an assessment of atherectomy as a primary strategy for calcified lesions and it's interesting that that was not as good efficacy. It was actually tents for worse TLR as compared to plain old balloon angioplasty and stent. Would like to ask Dr. Ott what is your kind thoughts about the alone atherectomy give the results of the study? Are they still doing it or is it falling out of favor? Dr. Ilka Ott:                         Yes, I think this is a very important point. I think atherectomy alone is not an appropriate treatment but there are some data that atherectomy in combination with drug-eluting balloon gives much better results, or you may even think about a combination of atherectomy and drug-eluting stent, so it often is the case. This study also raises a lot of questions and gives some thought into further studies. I think in the combination atherectomy might still have its place. Dr. Carolyn Lam:               Could you tell us some of those plans for future studies? Dr. Ilka Ott:                         Well, we are just in the initiation phase but I think one also very interesting concept is to compare drug-eluting balloon plus stent to the drug-eluting stents that have been on the market. However, as I said before, there's again the concept if you combine the drug-eluting balloon plus a stent it might be also, from the commercial aspect, better because sometimes you don't need the stent. And then moreover, the drug-eluting stents are much more expensive. It would be interested to see a study like that. Dr. Carolyn Lam:               What about the concern that the superficial femoral artery is subject to a lot of stretching and external compression and it's long and ... Maybe I'm out of date here about the concern of stent fractures and so on. It looks like your study has disproven this, or do you think the follow-up's long enough? Dr. Ilka Ott:                         I think the follow-up of two years is quite good, but you're right, it seems like in the superficial femoral artery the restenosis process is much longer and more prolonged. Of course, you would like not to place a stent in the SSA but from the interventional aspect, it's often not possible because if you have a dissection with a limiting the flow, you have to fix that by putting in a stent. Nitinol stents are pretty good these days. Moreover, we have another generation of the woven stents the Supera stents that might also be an interesting point to investigate in comparison to the strategy we now have shown to be superior. Dr. Manos Brilakis:           I think what we need is more studies like this, that they take the other modalities like atherectomy, laser and combine them with what is currently the standard of care, which is drug-coated balloons or drug-coated balloons plus stent, as shared in the study. I just want to congratulate Dr. Ott on her study and encourage future studies from the group. I know the ISAR group is been a phenomenally productive group in coronary intervention and I'm delighted to see they're expanding on the peripheral world. Dr. Carolyn Lam:               I couldn't agree more. Congratulations, once again, for a study that really will impact practice and that we're so proud to be publishing in Circulation.                                                 Listeners, I'm sure you learned as much as me, so please don't forget to tune in next week as well. Thanks.

Dr. Dyehouse is a medical oncologist and hematologist with Oncology Hematology Care, Inc. and The Jewish Hospital. She is here today to talk about a new program available at The Jewish Hospital.

This is Special English. I&`&m Mark Griffiths in Beijing. Here is the news.Chinese lawmakers have called for stricter management of traditional Chinese medicine production.During panel deliberations recently, legislators discussed a draft law on Traditional Chinese Medicine, tabled for a third reading at the bimonthly session of the National People&`&s Congress Standing Committee. The legislators agreed that the quality and safety of Traditional Chinese Medicine materials should be ensured with improved regulations.Legislator Jia Chunmei said during the discussion that bad materials lead to ineffective treatments, and cause people to mistrust Traditional Chinese Medicine.Legislators applauded the draft as it stresses enhanced supervision over farms producing Chinese medicine materials, adding that growth hormones used for herb cultivation should be brought under control.Legislator Zhang Boli said the overuse of growth hormones will sacrifice quality for quantity.Meanwhile, legislators urged specific rules that clarify the civil and criminal responsibilities of those who violate the Traditional Chinese Medicine law. This is Special English.Anhui Province in eastern China will be the first in the country to drop the Public English Test System, an English proficiency test for Chinese students. The province will stop using the system this year and more areas will follow suit.China plans to finally combine the two most popular English proficiency tests into one by 2020. China has around 300 million English learners who often have to take multiple, overlapping English tests. The Ministry of education has revealed that a new English proficiency evaluation system will be put into use this year and may be put forward across China by 2020.The new system will correspond with international standards and set nine grades for testers ranging from elementary school graduates to English majors and exceptional talents.You&`&re listening to Special English. I&`&m Mark Griffiths in Beijing.Facebook is taking new measures to curb the spread of fake news on its huge and influential social network. Focusing on the worst offenders, Facebook will partner with outside fact-checkers and news organizations to sort honest news reports from made-up stories that play on people&`&s passions and preconceived notions.Facebook will make it easier for users to report fake news, in only two steps when they see it. If enough people report a story as fake, Facebook will pass it to third-party fact-checking organizations that are part of the nonprofit Poynter Institute&`&s International Fact-Checking Network.Five fact-checking and news organizations are working with Facebook on this, including ABC News and The Associated Press, and the group is likely to expand.Stories that failed the fact check won&`&t be removed from Facebook, but they&`&ll be publicly flagged as "disputed", which will force them to appear lower down in people&`&s news feeds. Users will be able to click on a link to learn why that is. And if people decide they want to share the story with friends anyway, they can, but they&`&ll get another warning.This is Special English.German officials are stepping up their criticism of Facebook, saying the social network is doing too little to stop hate speech and could face stiff fines unless it deletes illegal content faster.In an interview published recently, Justice Minister Heiko Maas said his ministry was checking whether it would be possible to make social networking sites legally liable for illegal posts.Maas told media that if other measures fail to work, they have to think about fines in the end, and that would be a strong incentive to act quickly.Germany has seen a sharp increase in vitriolic posts on social media in recent years amid a heated public debate over the influx of more than a million migrants since the start of 2015.The country has laws against speech deemed to be racist, defamatory or inciting violence, a response to Germany&`&s Nazi legacy. But authorities have struggled with the deluge of often anonymous postings on foreign-owned websites.Facebook, based in California in the United States, says it takes the issue seriously and has hundreds of contractors reviewing posts at a Berlin office. But it is reported that staff members there complain of inconsistent rules and overwork.You&`&re listening to Special English. I&`&m Mark Griffiths in Beijing.The United Nations children&`&s fund and its partners have kicked off a mass measles vaccination drive, aiming to vaccinate 54,000 children under 10 years of age in southern Somalia.The United Nations Children&`&s Fund, UNICEF, says the vaccination drive follows a serious of outbreaks in southern Somalia.A UNICEF representative in Somalia says measles is one of the most deadly vaccine-preventable diseases but sadly, it is far from being the only one in Somalia.Many of the children suspected of suffering from measles in Kismayo had not been vaccinated against the disease, although there are 16 free vaccination posts in the area.The U.N. agency has supported the swift delivery of 55,000 doses of measles vaccine to the area along with Vitamin A supplementation to boost immunity. The vaccines are funded by the Office of U.S. Foreign Disaster Assistance, and Japan.According to UNICEF, measles is a key indicator of the strength of a country&`&s immunization systems. Somalia has one of the lowest immunization rates in the world. Measles is a highly contagious viral disease and a leading cause of death among young children in Somalia.This is Special English.U.S. researchers have found that a low-dose of aspirin may inhibit the normal function of blood platelets and reduce their ability to up-regulate a protein which plays an important role in cancer cell proliferation and survival. The mechanism means that low-dose aspirin, or "baby aspirin", may have some benefits in helping cancer prevention, especially colon cancer, in addition to protection against cardiovascular disease. The researchers from Oregon State University say the benefit of aspirin may be due to its effect on blood cells called platelets, rather than acting directly on tumor cells.Early cancer cells live in what&`&s actually a pretty hostile environment, where the immune system regularly attacks and attempts to eliminate them. Platelets can play a protective role for those early cancer cells. Inhibition with aspirin appears to interfere with that process.For the first time, the study shows the ability of platelets to regulate cancer cells.The anti-cancer benefit of aspirin occurs at very low doses. Higher doses are used to treat inflammation, headaches or pain. The new findings have enabled doctors to use low doses of aspirin, to minimize the risk of inner bleeding. Inner bleeding is a serious concern with any anti-platelet medication. You&`&re listening to Special English. I&`&m Mark Griffiths in Beijing. You can access the program by logging on to newsplusradio.cn. You can also find us on our Apple Podcast. If you have any comments or suggestions, please let us know by e-mailing us at mansuyingyu@cri.com.cn. That&`&s mansuyingyu@cri.com.cn. Now the news continues.French car maker Renault has opened China&`&s first experimental zone for self-driving cars in the central Chinese city of Wuhan.An electric autonomous driving, or AD, car by Renault has started operating on a 2-kilometer-long lakeside road in the Sino-French Wuhan Ecological Demonstration City.Visitors are allowed to experience the autonomous vehicle in the zone, which was jointly built by Renault and its Chinese cooperation partner, the Dongfeng Company.Autonomous systems can make car travel safer and passengers less stressed. It will make driving more enjoyable in tedious conditions, including traffic congestion.The Renault Group plans to gradually introduce the "eyes off" technology in its core range of vehicles by 2020. Drivers are also expected to be able to take advantage of in-car connectivity safely when conditions and the law permit.You&`&re listening to Special English. I&`&m Mark Griffiths in Beijing.Babies born with congenital Zika virus infection may develop microcephaly, or abnormal smallness of the head, months after birth.The U.S. Centers for Disease Control and Prevention published its latest Morbidity and Mortality Weekly Report. The report described 13 infants in Brazil with congenital Zika virus infection who did not have microcephaly at birth, but experienced slowed head growth as early as five months after birth.Among the infants, 11 later developed microcephaly.Congenital Zika virus infection without microcephaly at birth has been reported previously.However, this is the first series of infants with laboratory evidence of congenital Zika virus infection documented to have poor head growth with microcephaly developing after birth.The new findings have raised the alarm for the seemingly healthy babies born to mothers who were infected with the Zika virus worldwide.This is Special English.A report has found that Australia&`&s use of illegal methamphetamines including ice is at an all-time high.Odyssey House, one of Australia&`&s largest drug rehabilitation organizations based in Melbourne released its annual report recently. It said the number of people who admitted to amphetamine use went up 53 percent in 2016.The report said that half of the amphetamine users in Australia were seeking help for their addiction while heroin and opium use went down 45 percent last year.The report says the growth in ice addiction was proof that the Australian government needed to increase long-term funding to fight ice addiction.The report found that two thirds of Australian drug users last year were over the age of 30, with users reporting their first intoxication at a much earlier age than a decade ago.You&`&re listening to Special English. I&`&m Mark Griffiths in Beijing.The surgeon who created the life-saving Heimlich maneuver for choking died in Cincinnati in the United States recently. Dr. Henry Heimlich died of a heart attack at the age of 96.Heimlich&`&s son, Phil Heimlich, said his father was a great man who saved many lives, and he will be missed not only by his family but by all of humanity.Dr. Heimlich was director of surgery at the Jewish Hospital in Cincinnati in 1974 when he devised his treatment to reverse choking that made his name a household word in the United States.Rescuers using the procedure abruptly squeeze a victim&`&s abdomen, pushing in and above the navel with the fist to create a flow of air from the lungs. The flow of air can then push objects out of the windpipe and prevent suffocation.The maneuver has saved the lives of thousands in the United States alone. It earned Dr. Heimlich several awards and worldwide recognition. The maneuver was adopted by public health authorities, airlines and restaurant associations across the world.This is Special English.Lights, baubles and other decorations are often used to decorate Christmas trees in Australia during the festive season, but one local woman was shocked to find a tiger snake playing the part of the tinsel.After spotting the stowaway snake wrapped around the tree in her home, the woman called a professional snake handler Barry Goldsmith who happily relocated the "moving decoration".Goldsmith&`&s photo of the slippery critter went viral on Australia&`&s social media overnight. He told the Australian Broadcasting Corporation that he&`&d never seen anything quite like it.He said that although he has found snakes around the base of Christmas trees in amongst the presents in the past, he has never found one up inside a Christmas tree.Goldsmith said it is a one-off thing, like lightning striking, and it&`&s not going to happen again for sure, not this year.（全文见周六微信。）

Dr. Mackelaite is on faculty at the University of Louisville and does a significant amount of work with renal transplantation. She is one of the teaching faculty for the renal elective rotation which includes the transplant center at Jewish Hospital. This is a practical lecture on the topic of transplant with a focus on evaluation, qualification, benefits, and management. You can find her faculty profile here: http://louisville.edu/medicine/departments/medicine/doctors/mackelaite